Santos David A (CIK 1820066) reported 7 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-06-03). Recent activity: Sell RIGL (874 shares), Buy RIGL (19,430 shares), Sell RIGL (3,546 shares), Sell RIGL (5,718 shares), Sell RIGL (2,125 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-06-03 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Sell | 874 | $26,098 |
| 2026-02-19 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Buy | 19,430 | $0 |
| 2026-02-12 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Sell | 3,546 | $122,763 |
| 2026-02-04 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Sell | 5,718 | $205,905 |
| 2025-02-06 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Sell | 2,125 | $44,455 |
| 2025-02-06 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Sell | 1,796 | $39,386 |
| 2025-01-31 | RIGEL PHARMACEUTICALS INC (RIGL) | EVP, Chief Commercial Officer | Buy | 19,717 | $0 |
Source: SEC Form 4 filings · as of 2026-06-03